REN and Hyperkalemia: The concomitant use of inhibitors of the renin–angiotensin–aldosterone system and potassium can lead to potentially fatal hyperkalemia, especially in patients with impaired renal function, and should therefore only be used under close laboratory monitoring.51 Mirtazapine has many known drug interactions, also with easily available over-the-counter medicines.52